Fidelity Investments
RPTP

Fidelity Investments’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Fidelity Investments’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,463,302
Closed -$24M – 2784
2016
Q2 		$24M Hold
4,463,302
– – ﹤0.01% 1589
2016
Q1 		$20.5M Buy
4,463,302
+854,772
+24% +$3.44M ﹤0.01% 1651
2015
Q4 		$18.8M Hold
3,608,530
– – ﹤0.01% 1710
2015
Q3 		$21.8M Hold
3,608,530
– – ﹤0.01% 1624
2015
Q2 		$57M Hold
3,608,530
– – 0.01% 1285
2015
Q1 		$39.2M Buy
3,608,530
+512,500
+17% +$5.23M 0.01% 1442
2014
Q4 		$32.6M Buy
3,096,030
+14,600
+0.5% +$143K ﹤0.01% 1529
2014
Q3 		$29.6M Hold
3,081,430
– – ﹤0.01% 1555
2014
Q2 		$35.6M Sell
3,081,430
-250,800
-8% -$2.28M ﹤0.01% 1512
2014
Q1 		$33.3M Hold
3,332,230
– – ﹤0.01% 1523
2013
Q4 		$43.4M Sell
3,332,230
-409,250
-11% -$5.64M 0.01% 1380
2013
Q3 		$55.9M Buy
3,741,480
+409,250
+12% +$4.9M 0.01% 1225
2013
Q2 		$31.2M Buy
+3,332,230
New +$22.6M 0.01% 1466

Other funds holding RPTP

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Fidelity Investments's RPTP Position: Q3 2016 in Review

Fidelity Investments sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 4,463,302 shares — an estimated $24M sold.

Fidelity Investments first reported a position in RPTP in Q2 2013 and held it in 13 quarters. The position peaked at $57M in Q2 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Fidelity Investments reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Fidelity Investments sold 4,463,302 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $24M.
  • Fidelity Investments first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • Fidelity Investments's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $57M in Q2 2015.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Fidelity Investments's 13F filing for Q3 2016, filed 14 Nov 2016.